New Jersey A4311 requires Medicaid coverage for remote stress tests for pregnant women.
New Jersey A4311 mandates that the Medicaid Program include coverage for non-stress tests for pregnant women with high-risk pregnancies. These tests, approved by the U.S. Food and Drug Administration for at-home use, monitor fetal and maternal heart rate and uterine activity. The bill aims to address the issue where only 40% of high-risk pregnant women undergo prescribed contraction stress tests, which can worsen health issues and contribute to maternal mortality. By allowing for at-home testing, the bill seeks to improve access and outcomes for these women.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.